LX

Lexington Biosciences Holdings CorpOOTC LXGTF Stock Report

Last reporting period 31 Dec, 2022

Updated 14 Nov, 2024

Last price

Market cap $B

0.003

Micro

Exchange

OOTC - OTC

LXGTF Stock Analysis

LX

Uncovered

Lexington Biosciences Holdings Corp is uncovered by Eyestock quantitative analysis.

Market cap $B

0.003

Dividend yield

Shares outstanding

3.787 B

Lexington Biosciences, Inc. is a medical device company, which engages in the research and development of non-diagnostic devices. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2017-06-01. The device measures the function of the endothelium, the cells that line all arteries and are critical to the prevention of atherosclerosis, heart attacks and stroke. The firm is in the final stages of releasing the developed product for clinical studies. The firm's goal is to make HeartSentry accurate, quick, and cost effective so it can become the standard of care for cardiologists, general practitioners, and ultimately patients for first line evaluation of a person’s cardiovascular health.

View Section: Eyestock Rating